Eric C. Churchill

Family Medicine
140 High St # C
Springfield, MA 01105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner.

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner.

Journal: Journal of hematology & oncology
Published: November 01, 2011
Showing 1-1 of 1

Last Updated: 09/26/2026